Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) FCF Margin (2024 - 2025)

Historic FCF Margin for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to 109000.0%.

  • Connect Biopharma Holdings' FCF Margin fell 1079209200.0% to 109000.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 5643.83%, marking a year-over-year decrease of 38612200.0%. This contributed to the annual value of 93.58% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Connect Biopharma Holdings reported FCF Margin of 109000.0% as of Q3 2025, which was down 1079209200.0% from 26862.5% recorded in Q2 2025.
  • Over the past 5 years, Connect Biopharma Holdings' FCF Margin peaked at 377.08% during Q4 2024, and registered a low of 109000.0% during Q3 2025.